Go to content
UR Home

Entries of Daneshmand, Siamak on the publication server

Up a level
Export as
[feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item type | No Grouping
Jump to: 2022 | 2018 | 2016
Number of items: 5.

2022

Einerhand, Sarah M. H., Black, Anna J., Zargar, Homayoun , Fairey, Adrian S., Dinney, Colin P., Mir, Maria C., Krabbe, Laura-Maria, Cookson, Michael S., Jacobson, Niels-Erik, Montgomery, Jeffrey S., Vasdev, Nikhil , Yu, Evan Y., Xylinas, Evanguelos, Kassouf, Wassim, Dall’Era, Marc A., Sridhar, Srikala S., McGrath, Jonathan S., Aning, Jonathan, Shariat, Shahrokh F., Wright, Jonathan L., Thorpe, Andrew C., Morgan, Todd M. , Holzbeierlein, Jeff M., Bivalacqua, Trinity J., North, Scott, Barocas, Daniel A., Lotan, Yair, Grivas, Petros, Garcia, Jorge A., Stephenson, Andrew J., Shah, Jay B., Daneshmand, Siamak, Zargar-Shoshtari, Kamran, Spiess, Philippe E., van Rhijn, Bas W. G., Black, Peter C. and Mertens, Laura S. (2022) Multicenter evaluation of neoadjuvant and induction gemcitabine–carboplatin versus gemcitabine–cisplatin followed by radical cystectomy for muscle-invasive bladder cancer. World Journal of Urology 40 (11), pp. 2707-2715. Fulltext not available.

Pal, Sumanta K., Somford, Diederik M., Grivas, Petros, Sridhar, Srikala S., Gupta, Shilpa, Bellmunt, Joaquim, Sonpavde, Guru, Fleming, Mark T., Lerner, Seth P., Loriot, Yohann, Hoffman-Censits, Jean, Valderrama, Begoña P., Andresen, Corina, Schnabel, Marco J., Cole, Suzanne and Daneshmand, Siamak (2022) Targeting FGFR3 alterations with adjuvant infigratinib in invasive urothelial carcinoma: the phase III PROOF 302 trial. Future Oncology 18 (21), pp. 2599-2614. Fulltext not available.

2018

Gakis, Georgios, Schubert, Tina, Morgan, Todd M., Daneshmand, Siamak, Keegan, Kirk A., Mischinger, Johannes, Clayman, Rebecca H., Brisuda, Antonin , Ali-El-Dein, Bedeir , Galland, Sigolene, Gregg, Justin, Balci, Melih , Olugbade, Kola, Rink, Michael, Fritsche, Hans-Martin, Burger, Maximilian, Babjuk, Marko, Stenzl, Arnulf, Thalmann, George N., Kübler, Hubert and Efstathiou, Jason A. (2018) The prognostic effect of salvage surgery and radiotherapy in patients with recurrent primary urethral carcinoma. Urologic Oncology: Seminars and Original Investigations 36 (1), 10.e7-10.e14. Fulltext not available.

2016

Gakis, Georgios, Efstathiou, Jason A., Daneshmand, Siamak, Keegan, Kirk A., Clayman, Rebecca H., Hrbacek, Jan, Ali-El-Dein, Bedeir , Zaid, Harras B., Schubert, Tina, Mischinger, Johannes, Todenhoefer, Tilman, Galland, Sigolene, Olugbade, Kola Jr., Rink, Michael, Fritsche, Hans-Martin, Burger, Maximilian, Chang, Sam S., Babjuk, Marko, Babjuk, Marko, Thalmann, George N., Stenzl, Arnulf and Morgan, Todd M. (2016) Oncological Outcomes of Patients with Concomitant Bladder and Urethral Carcinoma. Urologia Internationalis 97 (2), pp. 134-141.

Gakis, Georgios, Morgan, Todd M., Efstathiou, Jason A., Keegan, Kirk A., Mischinger, Johannes, Todenhoefer, Tilman, Schubert, Tina, Zaid, Harras B., Hrbacek, Jan, Ali-El-Dein, Bedeir , Clayman, Rebecca H., Galland, Sigolene, Olugbade, Kola, Rink, Michael, Fritsche, Hans-Martin, Burger, Maximilian, Chang, Sam S., Babjuk, Marko, Thalmann, George N., Stenzl, Arnulf and Daneshmand, Siamak (2016) Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma. World Journal of Urology 34 (1), pp. 97-103. Fulltext not available.

This list was generated on Fri Dec 6 14:59:45 2024 CET.
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons